Evaluation of the International Society for Heart Transplantation (ISHT) grading of pulmonary rejection in 100 consecutive biopsies
Heart-lung and lung transplantation are accepted treatments for patients with end-stage pulmonary vascular disease or parenchymal lung disease [4, 5, 10]. Survival rates for heart-lung and lung transplantation are lower than those for heart transplantation alone. The 5-year actuarial survival forheart-lung transplantation has been 41% largely due to rejection and infection remaining as the limiting factors for long-term survival .
Key wordsPulmonary rejection ISHT grading TBBs histology
Unable to display preview. Download preview PDF.
- 2.Higenbottam T, Stewart S, Wallwork J (1988) Transbronchial lung biopsy to diagnose lung rejection and infection of heart-lung transplants. Transplant Proc 20:767–769Google Scholar
- 8.Stewart S, Higenbottam TW, Hutter JW, Penketh ARL, Zebro TJ, Wallwork J (1988) Histopathology of transbronchial biopsies in heart-lung transplantation. Transplant Proc 20:764–766Google Scholar
- 12.Yousem SA, Berry GJ, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, Stewart S, Tazelaar H (1990) A working formulation for the standardisation of nomenclature in the diagnosis of the heart and lung rejection: Lung Rejection Study Group. J Heart Transplant 9:593–601Google Scholar